Filing Details

---

1	NAMES OF REPORTING PERSONS
	OCM Value SPAC Holdings, L.P.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			0(1)
		6	SHARED VOTING POWER
		7	SOLE DISPOSITIVE POWER
			0(1)
		8	SHARED DISPOSITIVE POWER
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	0(1)
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	0.0%
12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	PN

---

(1)	Solely in its capacity as the general partner of Oaktree Capital I, L.P.

---

---

---

---

 

Zyversa Therapeutics, Inc.  (formerly known as Larkspur Health Acquisition Corp.) 

 

 

The Company's principal executive offices are located at 2200 N. Commerce Parkway, Suite 208, Weston, Florida 33326. 

 

 

This Schedule 13G is filed jointly by each of the following persons (collectively, the “Reporting Persons”) pursuant to a joint filing agreement attached hereto as Exhibit 1:

 

 

 

 

 

 

 

 

 

 

 

The address of the principal business office of BAM and of the BAM Partnership is Brookfield Place, Suite 300, 181 Bay Street, P.O. Box 762, Toronto, Ontario, Canada M5J 2T3. The address of the principal business office of other Reporting Persons is 333 S. Grand Avenue, 28th Floor, Los Angeles, CA 90071.

 

 

Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"). 

 

98987D102

 

This Item 3 is not applicable.

 

 

The responses of the Reporting Persons to Rows 5-9 and 11 in each of their respective cover pages to this Schedule 13G are incorporated herein by reference.

OCM Value SPAC directly no longer holds any shares of common stock, $0.0001 par value of the Issuer.

Fund GP, in its capacity as the general partner of OCM Value SPAC, has the ability to direct the management of OCM Value SPAC’s business regarding the vote and disposition of any securities held by OCM Value SPAC; therefore, Fund GP may be deemed to have indirect beneficial ownership of any shares held by OCM Value SPAC.

GP I, in its capacity as the managing member of Fund GP, has the ability to direct the management of Fund GP’s business regarding the vote and disposition of any securities held by OCM Value SPAC; therefore, GP I may be deemed to have indirect beneficial ownership of any shares held by OCM Value SPAC.

Capital I, in its capacity as the general partner of GP I, has the ability to direct the management of GP I’s business regarding the vote and disposition of any securities held by OCM Value SPAC; therefore, Capital I may be deemed to have indirect beneficial ownership of any shares held by OCM Value SPAC.

Holdings I, in its capacity as the general partner of Capital I, has the ability to direct the management of Capital I’s business regarding the vote and disposition of any securities held by OCM Value SPAC; therefore, Holdings I may be deemed to have indirect beneficial ownership of any shares held by OCM Value SPAC.

Holdings, in its capacity as the managing member of Holdings I, has the ability to direct the management of Holdings I’s business regarding the vote and disposition of any securities held by OCM Value SPAC; therefore, Holdings may be deemed to have indirect beneficial ownership of any shares held by OCM Value SPAC.

OCG, in its capacity as the managing member of Holdings, has the ability to direct the management of Holdings’ business regarding the vote and disposition of any securities held by OCM Value SPAC; therefore, OCG may be deemed to have indirect beneficial ownership of any shares held by OCM Value SPAC.

OCGH GP, in its capacity as the managing member of OCG, has the ability to direct the management of Holdings’ business regarding the vote and disposition of any securities held by OCM Value SPAC; therefore, OCGH GP may be deemed to have indirect beneficial ownership of any shares held by OCM Value SPAC.

BAM, in its capacity as the indirect owner of the class A units of OCG, has the ability to appoint and remove certain directors of OCG, and, as such, may indirectly control the decisions of OCG regarding the vote and disposition of any securities held by OCM Value SPAC; therefore, BAM may be deemed to have indirect beneficial ownership of any shares held by OCM Value SPAC.

The BAM Partnership, which is the sole owner of Class B Limited Voting Shares of BAM, has the ability to appoint one half of the board of directors of BAM and, as such, may indirectly control the decisions of BAM regarding the vote and disposition of any securities held by OCM Value SPAC; therefore, the BAM Partnership may be deemed to have indirect beneficial ownership of any shares held by OCM Value SPAC.

 

 

If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒

 

 

This Item 6 is not applicable.

 

 

This Item 7 is not applicable.

 

 

This Item 8 is not applicable.

 

 

This Item 9 is not applicable.

 

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: February 14, 2023